Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013, Article ID 608683, 6 pages
http://dx.doi.org/10.1155/2013/608683
Clinical Study

Effects of Metoprolol and Nebivolol on Exercise Blood Pressure in Patients with Mild Hypertension

1Department of Cardiology, School of Medicine, Eskişehir Osmangazi University, 26000 Eskişehir, Turkey
2Department of Anatomy, School of Medicine, Eskişehir Osmangazi University, Eskişehir, Turkey

Received 11 August 2013; Accepted 15 September 2013

Academic Editors: E. T. Martin and K. Okamatsu

Copyright © 2013 Huseyin Ugur Yazici et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Filipovsky, P. Ducimetiere, and M. E. Safar, “Prognostic significance of exercise blood pressure and heart rate in middle-aged men,” Hypertension, vol. 20, no. 3, pp. 333–339, 1992. View at Google Scholar · View at Scopus
  2. R. Mundal, S. E. Kjeldsen, L. Sandvik, G. Erikssen, E. Thaulow, and J. Erikssen, “Exercise blood pressure predicts cardiovascular mortality in middle-aged men,” Hypertension, vol. 24, no. 1, pp. 56–62, 1994. View at Google Scholar · View at Scopus
  3. S. A. Weiss, R. S. Blumenthal, A. R. Sharrett, R. F. Redberg, and S. Mora, “Exercise blood pressure and future cardiovascular death in asymptomatic individuals,” Circulation, vol. 121, no. 19, pp. 2109–2116, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Kokkinos, A. Pittaras, A. Manolis, D. Manjoros, P. Narayan, and S. Singh, “Exercise blood pressure predicts left ventricular mass in pre-hypertensive, middle-aged men and women,” Circulation, vol. 110, article 2611, 2004. View at Google Scholar
  5. G. D. Lewis, P. Gona, M. G. Larson et al., “Exercise blood pressure and the risk of incident cardiovascular disease (from the Framingham Heart study),” American Journal of Cardiology, vol. 101, no. 11, pp. 1614–1620, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Anderson, C. N. Mhurchu, D. Scott, D. Bennett, K. Jamrozik, and G. Hankey, “Triggers of subarachnoid hemorrhage: role of physical exertion, smoking, and alcohol in the Australasian Cooperative Research on Subarachnoid Hemorrhage study (ACROSS),” Stroke, vol. 34, no. 7, pp. 1771–1776, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Kokkinos, C. Chrysohoou, D. Panagiotakos, P. Narayan, M. Greenberg, and S. Singh, “Beta-blockade mitigates exercise blood pressure in hypertensive male patients,” Journal of the American College of Cardiology, vol. 47, no. 4, pp. 794–798, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Arita, T. Hashizume, Y. Wanaka et al., “Effects of antihypertensive agents on blood pressure during exercise,” Hypertension Research, vol. 24, no. 6, pp. 671–678, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. J. B. Kostis, D. M. Shindler, A. E. Moreyra, M. C. Ruddy, S. Schneider, and N. Cosgrove, “Differential exercise effects of captopril and nadolol in patients with essential hypertension,” Angiology, vol. 43, no. 8, pp. 647–652, 1992. View at Google Scholar · View at Scopus
  10. A. V. Chobanian, G. L. Bakris, H. R. Black et al., “Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure,” Hypertension, vol. 42, no. 6, pp. 1206–1252, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Mancia, R. Fagard, K. Narkiewicz et al., “Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC),” European Heart Journal, vol. 28, no. 12, pp. 1462–1536, 2007. View at Google Scholar
  12. A. J. Bowman, C. P. L. H. Chen, and G. A. Ford, “Nitric oxide mediated venodilator effects of nebivolol,” British Journal of Clinical Pharmacology, vol. 38, no. 3, pp. 199–204, 1994. View at Google Scholar · View at Scopus
  13. N. Çaǧlar and I. Dincer, “Comparison between nebivolol and ramipril in patients with hypertension and left ventricular hypertrophy: a randomized open blinded end-point (PROBE) trial,” European Review for Medical and Pharmacological Sciences, vol. 15, no. 12, pp. 1359–1368, 2011. View at Google Scholar · View at Scopus
  14. N. Şen, Y. Tavil, H. Erdamar et al., “Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X,” Anadolu Kardiyoloji Dergisi, vol. 9, no. 5, pp. 371–379, 2009. View at Google Scholar · View at Scopus
  15. B. Altun, G. Acar, A. Akçay, A. Sökmen, H. Kaya, and S. Köroǧlu, “Comparative effects of nebivolol and valsartan on atrial electromechanical coupling in newly diagnosed stage 1 hypertensive patients,” Turk Kardiyoloji Dernegi Arsivi, vol. 39, no. 7, pp. 563–567, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Akçay, G. Acar, E. Kurutas et al., “Beneficial effects of nebivolol treatment on oxidative stress parameters in patients with slow coronary flow,” Turk Kardiyoloji Dernegi Arsivi, vol. 38, no. 4, pp. 244–249, 2010. View at Google Scholar
  17. G. F. Fletcher, G. Balady, L. H. Hartley, V. F. Froelicher, W. L. Haskell, and M. L. Pollock, “Exercise standards: a statement for healthcare professionals from the American Heart Association,” Circulation, vol. 91, no. 2, pp. 580–615, 1995. View at Google Scholar · View at Scopus
  18. M. S. Lauer, D. Levy, K. M. Anderson, and J. F. Plehn, “Is there a relationship between exercise systolic blood pressure response and left ventricular mass? The Framingham Heart study,” Annals of Internal Medicine, vol. 116, no. 3, pp. 203–210, 1992. View at Google Scholar · View at Scopus
  19. J. S. Gottdiener, J. Brown, J. Zoltick, and R. D. Fletcher, “Left ventricular hypertrophy in men with normal blood pressure: relation to exaggerated blood pressure response to exercise,” Annals of Internal Medicine, vol. 112, no. 3, pp. 161–166, 1990. View at Google Scholar · View at Scopus
  20. R. B. Devereux and T. G. Pickering, “Relationship between ambulatory or exercise blood pressure and left ventricular structure: prognostic implications,” Journal of Hypertension, vol. 8, no. 6, pp. S125–S134, 1990. View at Google Scholar · View at Scopus
  21. P. O. Lim, P. T. Donnan, and T. M. Macdonald, “How well do office and exercise blood pressures predict sustained hypertension? A Dundee Step Test study,” Journal of Human Hypertension, vol. 14, no. 7, pp. 429–433, 2000. View at Google Scholar · View at Scopus
  22. R. Fagard, J. Staessen, L. Thijs, and A. Amery, “Prognostic significance of exercise versus resting blood pressure in hypertensive men,” Hypertension, vol. 17, no. 4, pp. 574–578, 1991. View at Google Scholar · View at Scopus
  23. G. F. Fletcher, G. J. Balady, E. A. Amsterdam et al., “Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association,” Circulation, vol. 104, no. 14, pp. 1694–1740, 2001. View at Google Scholar · View at Scopus
  24. S. Nodari, M. Metra, and L. dei Cas, “β-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol,” European Journal of Heart Failure, vol. 5, no. 5, pp. 621–627, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Stoschitzky, G. Stoschitzky, H. Brussee, C. Bonell, and H. Dobnig, “Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol,” Cardiology, vol. 106, no. 4, pp. 199–206, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Oǧuz, M. Uzunlulu, E. Yorulmaz, Y. Yalçin, N. Hekim, and F. Fici, “Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus,” Anadolu Kardiyoloji Dergisi, vol. 7, no. 4, pp. 383–387, 2007. View at Google Scholar · View at Scopus
  27. T. Celik, A. Iyisoy, H. Kursaklioglu et al., “Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients,” Journal of Hypertension, vol. 24, no. 3, pp. 591–596, 2006. View at Google Scholar · View at Scopus
  28. P. Kampus, M. Serg, J. Kals et al., “Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness,” Hypertension, vol. 57, no. 6, pp. 1122–1128, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Taddei, A. Virdis, L. Ghiadoni, I. Sudano, and A. Salvetti, “Effects of antihypertensive drugs on endothelial dysfunction: clinical implications,” Drugs, vol. 62, no. 2, pp. 265–284, 2002. View at Google Scholar · View at Scopus